Tandem Diabetes Care Inc
Research Tandem Diabetes Care Inc (TNDM) on Bullrun: market cap USD 1.50B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTNDM
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 1.50B
- Financial periodQ2 2026
- RevenueUSD 254.56M
- Net income-USD 21.17M
- Free cash flow-USD 38.68M
- Gross margin56.9%
Valuation Snapshot
latest market cap is USD 1.50B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 1.01B | -USD 204.70M | -USD 29.67M | 53.8% | -3.04 | USD 90.63M | USD 310.04M | USD 155.17M |
| FY2024 | USD 940.20M | -USD 96.00M | USD 4.99M | 52.1% | -1.47 | USD 69.23M | USD 348.94M | USD 263.10M |
| FY2023 | USD 747.72M | -USD 222.60M | -USD 58.61M | 49.2% | -3.43 | USD 58.87M | USD 285.04M | USD 313.63M |
| FY2022 | USD 801.22M | -USD 94.60M | USD 16.37M | 51.5% | -1.47 | USD 172.52M | USD 422.07M | USD 439.95M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.50B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 1.50B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 2.39B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 1.93B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 2.89B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 9.61B | 654.4 | n/a | n/a |
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Tandem Diabetes Care Inc's market cap?
Tandem Diabetes Care Inc's market capitalization is USD 1.50B.
What does Tandem Diabetes Care Inc do?
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.